Remdesivir, an intravenous antiviral drug, is used to treat mild to moderate COVID-19 in adults and adolescents (≥ 12 years old and weighing ≥ 40 kilograms) who have positive results of direct SARS-CoV-2 viral testing and who are at high risk for progression to severe COVID-19.